Share
“Civilization begins with distillation,” said William Faulkner, a writer and drinker. Although our thirst for alcohol dates back to the Stone Age, nobody has figured out a good way to deal with the ensuing hangover after getting drunk.
As a chemical engineering professor and wine enthusiast, I felt I needed to find a solution. As frivolous as this project may sound, it has serious implications. Between 8 and 10 percent of emergency room visits in America are due to acute alcohol poisoning. Alcohol is the leading risk factor for premature deaths and disability among people aged 15-49 and its abuse leads to serious health problems, including cardiovascular and liver cancer. Despite these sobering facts, current treatments for alcohol overdose largely rely on the body’s own enzymes to break down this drug.

Yunfeng Lu
Together with professor Cheng Ji, an expert in liver diseases from Keck School of Medicine at the University of Southern California, and my graduate student Duo Xu, we developed an antidote and tested it in mice.
To protect the enzymes, we wrapped each of them in a shell, using a material the U.S. Food and Drug Administration had already approved for pills. We then injected these nanocapsules into the veins of drunk mice where they hurtled through the circulatory system, eventually arriving in the liver where they entered the cells and served as mini–reactors to digest alcohol.
We showed that in inebriated mice (which fall asleep much faster than drunk humans), the treatment decreased the blood alcohol level by 45 percent in just four hours compared to mice that didn’t receive any. Meanwhile, the blood concentration of acetaldehyde – a highly toxic compound that is carcinogenic, causes headaches and vomiting, makes people blush after drinking, and is produced during the normal alcohol metabolism – remained extremely low. The animals given the drug woke from their alcohol-induced slumber faster than their untreated counterparts – something all college students would appreciate.
We are currently completing tests to ensure that our nanocapsules are safe and don’t trigger unexpected or dangerous side effects. If our treatments prove effective in animals, we could begin human clinical trials in as early as one year.

Yunfeng Lu, Professor Chemical and Biomolecular Engineering, University of California, Los Angeles
This article was originally published on The Conversation. Read the original article.
Bryan Kohberger Pleads Guilty in Murders of Four Idaho Students, ABC News Reports
1 hour ago
Fresno County CHP Arrest Two in Interstate 5 Drug, Gun, and Counterfeit Money Bust
2 hours ago
Where Trade Talks Stand With Major US Partners Ahead of Tariffs-Hike Deadline
2 hours ago
DOJ Announces Arrest, Indictments in North Korean IT Worker Scheme
2 hours ago
Fresno Man Arrested in Clovis for Sex-Related Crimes Against Minor
2 hours ago
Suspect Identified in Ambush Shooting That Killed 2 Idaho Firefighters
3 hours ago
Fresno Woman Killed in Head-On Collision, CHP Investigating
18 minutes ago
Categories

Fresno Woman Killed in Head-On Collision, CHP Investigating

Musk Vows to Punish Lawmakers Who Back Trump’s Spending Bill

Fresno Man Sentenced to Nearly 6 Years for $4.2 Million Tech Startup Fraud

Bryan Kohberger Pleads Guilty in Murders of Four Idaho Students, ABC News Reports

Fresno County CHP Arrest Two in Interstate 5 Drug, Gun, and Counterfeit Money Bust
